VicenteTorres RochesterUnited States

Wcn26 Post edited Speaker Card

Time	Session

2:10 p.m. 3:10 p.m.	ISN-PKDF Joint Session Introduction of Kaplan & Award Presentation VicenteTorres Chair United States TBA RonaldGansevoort Speaker Netherlands Platform trials in PKD: Opportunities and Challenges MegJardine Speaker Australia Is there a role for SGLT2 inhibitors and GLP analogues in treating PKD MichelChonchol Speaker United States 303